APA (7th ed.) Citation

J, Y., Z, T., Q, L., L, S., H, Z., & P, L. (2026). Therapeutic efficacy of the polidocanol versus pingyangmycin in the treatment of maxillofacial vascular disorders. Phlebology, 41(4), 337. https://doi.org/10.1177/02683555251365067

Chicago Style (17th ed.) Citation

J, Yang, Tan Z, Liu Q, Shen L, Zhang H, and Liu P. "Therapeutic Efficacy of the Polidocanol Versus Pingyangmycin in the Treatment of Maxillofacial Vascular Disorders." Phlebology 41, no. 4 (2026): 337. https://doi.org/10.1177/02683555251365067.

MLA (9th ed.) Citation

J, Yang, et al. "Therapeutic Efficacy of the Polidocanol Versus Pingyangmycin in the Treatment of Maxillofacial Vascular Disorders." Phlebology, vol. 41, no. 4, 2026, p. 337, https://doi.org/10.1177/02683555251365067.